A New Model to Predict Survival Time in Patients With Hepatocellular Carcinoma With BCLC Advanced Stage
Cancer Medicine · 2025
DOI: 10.1002/cam4.71299 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, 2025. Verfasst von Masashi Ninomiya und 23 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Tohoku University Hospital, Sendai, Japan. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The variety of treatments available makes it difficult to determine whether a treatment would be effective for an individual case in advanced‐stage hepatocellular carcinoma. We aimed to establish a new model of survival prediction in patients to establish standards in the recent and coming multimolecular targeted agents era. This analysis was prepared using a data set of 518 patients diagnosed with hepatocellular carcinoma prior to 2017. Multiple regression analysis showed the size of the largest tumor nodule, the number of nodules, macrovascular invasion, extrahepatic metastasis, total bilirubin, albumin, prothrombin time (PT), α‐fetoprotein, and des‐γ‐carboxyprothrombin (DCP) as independent predictors of survival. A Weibull model had the best fit and, based on these predictors, we established two new predicted survival models with or without incorporating PT and DCP. This model is useful for planning and evaluating the efficacy of recent sequential therapies in the multimolecular targeted agents era.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Gastroenterology, Tohoku University Hospital, Sendai, Japan.
- Gastroenterology Center, Ehime Prefectural Central Hospital, Ehime, Japan.
- Division of Gastroenterology and Hepatology, Department of Internal Medicine, Iwate Medical University, Iwate, Japan.
- Department of Gastroenterology, School of Medicine, Fukushima Medical University, Fukushima, Japan.
- Department of Gastroenterology, Faculty of Medicine, Yamagata University, Yamagata, Japan.
- Department of Gastroenterology, Graduate School of Medicine, Akita University, Akita, Japan.
ORCID-Profile: Masashi Ninomiya, Chikara Iino
Zitieren
APA
Ninomiya, M., Tsuruoka, M., Inoue, J., Hiraoka, A., Sano, A., Sato, K., Onuki, M., Sawahashi, S., Ouchi, K., Watanabe, K., Kuroda, H., Oikawa, T., Abe, T., Fujita, M., Abe, K., Katsumi, T., Sato, W., Igarashi, G., Iino, C., …, & Masamune, A. (2025). A New Model to Predict Survival Time in Patients With Hepatocellular Carcinoma With BCLC Advanced Stage. Cancer Medicine. https://doi.org/10.1002/cam4.71299
Vancouver
Ninomiya M, Tsuruoka M, Inoue J, Hiraoka A, Sano A, Sato K, et al. A New Model to Predict Survival Time in Patients With Hepatocellular Carcinoma With BCLC Advanced Stage. Cancer Medicine. 2025. doi:10.1002/cam4.71299
BibTeX
@article{Ninomiya2025,
author = {Ninomiya, Masashi and Tsuruoka, Mio and Inoue, Jun and Hiraoka, Atsushi and Sano, Akitoshi and Sato, Kosuke and Onuki, Masazumi and Sawahashi, Satoko and Ouchi, Keishi and Watanabe, Kengo and Kuroda, Hidekatsu and Oikawa, Takayoshi and Abe, Tamami and Fujita, Masashi and Abe, Kazumichi and Katsumi, Tomohiro and Sato, Wataru and Igarashi, Go and Iino, Chikara and Tanabe, Nobukazu and Numao, Hiroshi and Ohira, Hiromasa and Ueno, Yoshiyuki and Masamune, Atsushi},
title = {A New Model to Predict Survival Time in Patients With Hepatocellular Carcinoma With BCLC Advanced Stage},
journal = {Cancer Medicine},
year = {2025},
doi = {10.1002/cam4.71299}
}
EUVIMED